JPRN-UMIN000017487已完成未知
A phase III study comparing nab-paclitaxel with docetaxel in patients with previously treated advanced non-small-cell lung cancer - nab-PTX vs DTX Phase III
Research Institute for Diseases of the Chest, Kyushu University0 个研究点目标入组 500 人开始时间: 2015年5月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Treatment history of taxanes 2) Synchronous or metachronous active double malignancies 3) Infectious disease requiring systemic treatment 4) Fever of 38 degrees centigrade or higher 5) Psychotic disorder
研究者
相似试验
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
已完成
3 期
ab-PTX vs DTX Phase IIILung cancerJPRN-jRCTs071180037Okamoto Isamu503
招募中
2 期
Phase 2 study of dose-dense nab-paclitaxel followed by EC as neoadjuvant chemotherapy for HER2-negative breast cancerHER2-negative primary breast cancerJPRN-UMIN000026143Teikyo University School of Medicine50
已完成
不适用
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30
招募中
不适用
Observational study of Nab-paclitaxel followed by Anthracycline based regimen as preoperative chemotherapy for ER-negative resectable primary breast cancerBreast cancerJPRN-UMIN000020994SHINKO HOSPITA40